Latest Breaking News On - Rajender aparasu - Page 1 : comparemela.com

Pioneering CBD for epilepsy treatment and prevention

Pioneering CBD for epilepsy treatment and prevention
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of houstonUniversity of wisconsinRobert mbilinyiRama magantiSandipan patiMansoor khanSreevidhya ramakrishnanRajender aparasuDrug administrationTexasam university school of medicineTexas comprehensive epilepsy programTexasam healthDepartment of neuroscienceEpilepsy programUt mcgovern medical school

Pioneering CBD For Epilepsy Treatment And Prevention

Pharmacology research team reveals breakthrough findings on cannabinoid therapy for preventing epilepsy and refractory seizure disorders

United statesUniversity of wisconsinUniversity of houstonSandipan patiSreevidhya ramakrishnanMansoor khanRajender aparasuRobert mbilinyiDrug administrationA texasam universityTexasam university school of medicineEpilepsy programDepartment of neuroscienceTexas comprehensive epilepsy programPublic health in madisonTexasam health institute of pharmacology

Can elderly patients safely stop MS treatment? Study to find out | Urgent study by new US university center funded by $1 6M grant

Can elderly patients safely stop MS treatment? Study to find out | Urgent study by new US university center funded by $1 6M grant
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Rajender aparasuUniversity of houston college pharmacyAgency for healthcare researchPopulation health outcomesUniversity of houstonHuman servicesResearch centerUs department of healthPharmacoepidemiology educationHouston collegeHealthcare research

UH professor receives NIH grant for pharmaceutical research

UH professor receives NIH grant for pharmaceutical research Hua Chen has received a grant from the National Institute of Health to research how the diabetes drug Metformin could impact weight gain in children taking certain psychiatric medications. | Courtesy of Hua Chen Hua Chen, a professor in the College of Pharmacy’s study to explore whether the diabetes drug Metformin can be used to combat the weight gain caused by mental health medications in children and teenagers. Chen received a $455,000 grant from the National Institutes of Health to fund her research. She plans to use a national electronic medical record database to screen for those between the ages of six and nineteen who were given Metformin towards the beginning stages of their treatment with atypical/second generation antipsychotic drugs.

United statesTexas medical centerZhua chenRajender aparasuHealth outcomesHealth outcomesandNational institute of healthNational institutes of healthCollege of pharmacyNational institutePharmaceutical health outcomesand policyNational institutesPharmaceutical health outcomesHouston medication safety symposiumஒன்றுபட்டது மாநிலங்களில்டெக்சாஸ் மருத்துவ மையம்